FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

NAUTILUS BIOTECHNOLOGY, INC.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2021-06-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/63f689d3-c1fe-4e47-b269-de8ada5b1637

Reported value

$288.387M{"amount": 288387000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
NAUTILUS BIOTECHNOLOGY, INC.
Metric
cash_and_equivalents
Period
as of 2021-06-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001808805-21-000007 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:12:54.651344+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001808805/cash-and-equivalents/2021-06-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.